Profil
Ms. Loh Chin-Siew was formerly Head, Pharmaceuticals of the Biomedical Sciences Group at the Singapore Economic Development Board (EDB) where she was involved in developing strategies for the pharmaceuticals sector, and led the promotion efforts to encourage investments from global pharmaceutical companies.
Her principle areas of focus have been R&D and manufacturing, where she and her team successfully negotiated and secured several strategic investments in corporate R&D centres and manufacturing.
Ms. Loh completed her MBA at INSEAD in 2000.
At undergraduate level, she graduated with First Class Honours in Chemistry from the University of Bristol
Anciens postes connus de Loh Chin Siew
| Sociétés | Poste | Fin |
|---|---|---|
ProTherapeutics Pte Ltd.
 ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Directeur/Membre du Conseil | - |
| Singapore Economic Development Board | Corporate Officer/Principal | - |
Bio*One Capital Pte Ltd.
 Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Private Equity Investor | - |
Formation de Loh Chin Siew
| INSEAD | Masters Business Admin |
| University of Bristol | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| Singapore Economic Development Board | Government |
Bio*One Capital Pte Ltd.
Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Finance |
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |
